Serum Lp-PLA2 levels are linked to the advancement of coronary atherosclerotic plaques in individuals with T2DM and those without diabetes, implying that Lp-PLA2 plays a vital role as a mediator or marker in the development of atherosclerotic plaques. The gene discussed is PLA2G7; the disease is type 2 diabetes mellitus.